Design, synthesis and biological evaluation of amino organophosphorus imidazoles as a new type of potential antimicrobial agents

被引:0
作者
Wei-Wei Gao
Syed Rasheed
VijaiKumarReddy Tangadanchu
Yi Sun
Xin-Mei Peng
Yu Cheng
Feng-Xiu Zhang
Jian-Mei Lin
Cheng-He Zhou
机构
[1] Southwest University,Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering
[2] School of Medicine University of Electronic Science and Technology of China,undefined
来源
Science China Chemistry | 2017年 / 60卷
关键词
organophosphorus; imidazole; antibacterial; antifungal; HSA;
D O I
暂无
中图分类号
学科分类号
摘要
A series of amino organophosphorus imidazoles were designed and synthesized as a novel structural type of antimicrobial agents. Bioactive evaluation in vitro showed that compound 3f exhibited equipotent or superior anti-methicillin-resistant Staphylococcus aureus (anti-MRSA) and anti-S. cerevisiae efficiencies (minimal inhibitory concentration (MIC)=2 μg/mL) to clinical drugs, and the combinations with antibacterial or antifungal drugs enhanced the antimicrobial efficiency. Highly active molecule 3f showed low propensity for bacteria to develop resistance, and the preliminary action mechanism studies demonstrated that 3f was membrane-active, but had no significant intercalation towards MRSA DNA. The computational study on 3f reasonably explained its high antimicrobial activity. Experimental data revealed that ground-state 3f-HSA complexes were formed mainly through hydrophobic interactions and hydrogen bonds with a spontaneous process, and the non-radioactive energy transfer from HSA to 3f occurred beyond Förster resonance energy transfer theory. The participation of metal ions in 3f-HSA supramolucular system could increase the concentration of free compound 3f, and shorten its storage time and half-life in the blood to improve the maximum antimicrobial efficacy.
引用
收藏
页码:769 / 785
页数:16
相关论文
共 364 条
  • [1] Zhang J(2014)undefined J Am Chem Soc 136 4873-4876
  • [2] Chen YP(2014)undefined Mol Pharm 11 3528-3536
  • [3] Miller KP(2012)undefined Curr Med Chem 19 239-280
  • [4] Ganewatta MS(2015)undefined Prog Chem 27 704-743
  • [5] Bam M(2010)undefined Eur J Med Chem 45 4631-4639
  • [6] Yan Y(2014)undefined Med Res Rev 34 340-437
  • [7] Nagarkatti M(2013)undefined Eur J Med Chem 64 389-395
  • [8] Decho AW(2013)undefined Curr Pharm Des 19 3884-3930
  • [9] Tang C(2013)undefined Curr Top Med Chem 13 1963-2010
  • [10] Oh D(2016)undefined Bioorg Med Chem Lett 26 2768-2773